Yolanda Sáinz
About
In The Last Decade
Yolanda Sáinz
19 papers receiving 538 citations
Peers
Comparison fields: 5 of 58
- Organic Chemistry 490
- Molecular Biology 98
- Toxicology 83
- Pharmaceutical Science 44
- Cancer Research 27
Countries citing papers authored by Yolanda Sáinz
This map shows the geographic impact of Yolanda Sáinz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yolanda Sáinz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yolanda Sáinz more than expected).
Fields of papers citing papers by Yolanda Sáinz
This network shows the impact of papers produced by Yolanda Sáinz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yolanda Sáinz. The network helps show where Yolanda Sáinz may publish in the future.
Co-authorship network of co-authors of Yolanda Sáinz
This figure shows the co-authorship network connecting the top 25 collaborators of Yolanda Sáinz. A scholar is included among the top collaborators of Yolanda Sáinz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yolanda Sáinz. Yolanda Sáinz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 13 | |
| 2 | 19 | |
| 3 | 19 | |
| 4 | 65 | |
| 5 | 69 | |
| 6 | 13 | |
| 7 | New 3-[4-(aryl)piperazin-1-yl]-1-(benzo[b]thiophen-2-yl)propane derivatives with dual action at 5-HT1A serotonin receptors and serotonin transporter as a new class of antidepressants. | 3 |
| 8 | 1 | |
| 9 | Synthesis and antituberculosis activity of new 2-quinoxalinecarbonitrile 1,4-di-N-oxides. | 15 |
| 10 | 4 | |
| 11 | 12 | |
| 12 | 27 | |
| 13 | 12 | |
| 14 | 6 | |
| 15 | 107 | |
| 16 | 110 | |
| 17 | 28 | |
| 18 | 1 | |
| 19 | 25 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.